Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 5, keine Gesamtzahl für „studies“
Suchtreffer
Begriffe & Kennungen
Ahzantive · 4.8 · Table 1: All treatment-emergent adverse drug reactions reported in patients in phase III studies (pooled data
Eintrag öffnenAhzantive · 4.8 · Table 1: All treatment-emergent adverse drug reactions reported in patients in phase III studies (pooled data
Eintrag öffnenAhzantive · 4.8 · The safety data described below include all adverse reactions from the eight phase III studies in the indicati
Eintrag öffnenAimovig · 4.8 · Cutaneous and hypersensitivity reactions In the integrated 12-week placebo-controlled phase of the studies, no
Eintrag öffnenAimovig · 4.8 · Immunogenicity During the double-blind treatment phase of the clinical studies, the incidence of anti-erenumab
Eintrag öffnenAimovig · 4.8 · Injection site reactions In the integrated 12-week placebo-controlled phase of the studies, injection site rea
Eintrag öffnenAjovy · 4.5 · No formal clinical drug interaction studies have been performed with AJOVY. No pharmacokinetic drug interactio
Eintrag öffnenAjovy · 4.8 · ADRs from clinical studies and post-marketing reports are presented according to MedDRA system organ classific
Eintrag öffnenAjovy · 4.8 · Immunogenicity In placebo-controlled studies, 0.4 % of patients (6 out of 1,701) treated with fremanezumab dev
Eintrag öffnenAkeega · 4.8 · In the MAGNITUDE and AMPLITUDE studies, the following haematological parameters were inclusion criteria: absol
Eintrag öffnenAkeega · 4.8 · Table 3: Adverse reactions identified in clinical studies System Organ Class Frequency Adverse reaction Infect
Eintrag öffnenAkeega · 4.8 · Tabulated list of adverse reactions Adverse reactions observed during clinical studies are listed below by fre
Eintrag öffnenAldara · 4.5 · No interaction studies have been performed. This includes studies with immunosuppressive drugs. Interactions w
Eintrag öffnenAldara · 4.8 · Clinical studies investigating the use of imiquimod for the treatment of actinic keratosis have detected a 0.4
Eintrag öffnenAldara · 4.8 · Imiquimod was investigated in controlled clinical studies with paediatric patients (see sections 4.2 and 5.1).
Eintrag öffnenAldurazyme · 4.5 · No interaction studies have been performed. Based on its metabolism, laronidase is an unlikely candidate for C
Eintrag öffnenAldurazyme · 4.8 · In the Phase 2 and 3 studies, 60 patients were tested for in-vitro neutralising effects. Four patients (three
Eintrag öffnenAlimta · 4.5 · Pemetrexed undergoes limited hepatic metabolism. Results from in vitro studies with human liver microsomes ind
Eintrag öffnenAlli (previously Orlistat GSK) · 4.5 · In the absence of pharmacokinetic interaction studies, alli is not recommended to be used by patients receivin
Eintrag öffnenAlli (previously Orlistat GSK) · 4.5 · The vast majority of subjects receiving up to 4 full years of treatment with orlistat in clinical studies had
Eintrag öffnen